Compares treatment options for Plantar Fascia
Official title Effects of Low-Dye Taping Compared to Calcaneal Taping in Patients With Plantar Fasciitis
ClinicalTrials.gov ID: NCT07544732
What this study is testing
- What it's testing
- Plantar fasciitis is a common musculoskeletal condition characterized by inflammation and microtears of the plantar fascia, leading to heel pain, particularly during initial steps after rest. It negatively impacts gait, mobility, and overall quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 44
You may be able to join if
- Adults of 19 - 44 years old age.
- Both genders will be included
- Pain in plantar heel lasting more than three months
- Clinical diagnosis of unilateral PF in compliance with the American
- physical therapy association's (APTA) Orthopedic Section clinical practice
You likely can't join if
- Previous surgical intervention for plantar fasciitis.
- Congenital abnormalities of foot.
- Lower extremities affected by systemic disorders, such as rheumatoid arthritis,
- diabetes or peripheral neuropathy.
- The presence of additional foot disorders, such as stress fractures, Achilles
- tendinopathy, or nerve entrapment syndromes.
See the full eligibility criteria
- Adults of 19 - 44 years old age.
- Both genders will be included
- Pain in plantar heel lasting more than three months
- Clinical diagnosis of unilateral PF in compliance with the American
- physical therapy association's (APTA) Orthopedic Section clinical practice
- guidelines
- Positive windlass test
- Negative tarsal tunnel tests
- Limited active and passive talocrural joint dorsiflexion range of motion
- Pain on the inner side of the heel is most noticeable with the first steps after
- rest and tends to worsen after standing or walking for a long time.
- Willing and capable of adhering to the study procedure and completing follow-up
- examinations.
- Planter fascia tests i.e. windlass mechanism, hop test, stair climbing.
- Sedentary individuals (no exercise plan followed in last 3 months)
- Previous surgical intervention for plantar fasciitis.
- Congenital abnormalities of foot.
- Lower extremities affected by systemic disorders, such as rheumatoid arthritis,
- diabetes or peripheral neuropathy.
- The presence of additional foot disorders, such as stress fractures, Achilles
- tendinopathy, or nerve entrapment syndromes.
- Any contraindications to taping, such as skin sensitivity or allergy.
- Not willing or not capable of adhering to the study procedure and completing follow-
- up examinations.
- Pregnant women, mental illness, immune suppressed patients, patients with
- peripheral vascular disease, thrombocytopenia patients, anti-coagulant therapy
- patients and post mastectomy.
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 44 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.